Lanthanum Carbonate manufacturers
- LANTHANUM CARBONATE
-
- $50.00 / 1kg
-
2025-03-07
- CAS:587-26-8
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 15 tons
- Lanthanum Carbonate
-
- $20.00 / 25KG
-
2025-03-06
- CAS:587-26-8
- Min. Order: 1KG
- Purity: 99.9%
- Supply Ability: 1000KG
- LANTHANUM CARBONATE
-
- $0.00 / 1KG
-
2024-10-28
- CAS:587-26-8
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 500000kg
|
| | Lanthanum Carbonate Basic information |
| Product Name: | Lanthanum Carbonate | | Synonyms: | dilanthanum tricarbonate;Carbonic acid, lanthanum(3++) salt (3:2);LANTHANUM CARBONATE;LANTHANUM (III) CARBONATE;lanthanum(3+) tricarbonate;Lanthanum Carbonate powder;lanthanuM carbonat | | CAS: | 587-26-8 | | MF: | C3La2O9 | | MW: | 457.84 | | EINECS: | 209-599-5 | | Product Categories: | Inorganics | | Mol File: | 587-26-8.mol |  |
| | Lanthanum Carbonate Chemical Properties |
| density | 3.48[at 20℃] | | Water Solubility | 1.24mg/L at 20℃ | | InChI | InChI=1S/3CH2O3.2La/c3*2-1(3)4;;/h3*(H2,2,3,4);;/q;;;2*+3/p-6 | | InChIKey | NZPIUJUFIFZSPW-UHFFFAOYSA-H | | SMILES | [La+3].[La+3].C([O-])(=O)[O-].C([O-])(=O)[O-].C([O-])(=O)[O-] | | CAS DataBase Reference | 587-26-8 | | EPA Substance Registry System | Carbonic acid, lanthanum(3+) salt (3:2) (587-26-8) |
| Provider | Language |
|
ALFA
| English |
| | Lanthanum Carbonate Usage And Synthesis |
| Uses | Treatment of hyperphosphatae mia in patients with end stage renal disease. | | Brand name | Fosrenol
(Shire). | | Flammability and Explosibility | Not classified | | Mechanism of action |
Lanthanum Carbonate inhibits phosphate absorption from the intestine and lowers the phosphate levels in the blood. Lanthanum Carbonate inhibits phosphate absorption from the intestine and lowers the phosphate levels in the blood.
| | Side effects | Nausea, Vomiting, Abdominal pain | | in vitro | Lanthanum carbonate is an ideal phosphate binder. It prevents the adsorption of dietary phosphate by forming insoluble lanthanum phosphate. It has been reported that lanthanum carbonate binds phosphate optimally at pH 3–5, while retaining binding activity at pH 1–7. In vitro, studies suggest that the efficacy of lanthanum phosphate is comparable to that of aluminium compounds in binding with phosphate. The FDA has approved using lanthanum carbonate as a phosphate binder for renal failure patients. |
| | Lanthanum Carbonate Preparation Products And Raw materials |
|